Cancer cells induce abnormal blood coagulation through a process that probably involves a
combination of increased activators and deficiencies of anticoagulants. The probable
participating factors (including tissue factor-factor VII and cancer procoagulant) and their role
in this process are discussed. The current theory on the role of coagulation in malignant
disease is also discussed.